↓ Skip to main content

Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
Published in
Journal of Pharmaceutical Policy and Practice, February 2015
DOI 10.1186/s40545-015-0026-6
Pubmed ID
Authors

Norman C Morrow

Abstract

The formulation of pharmaceutical policy is a critical component of healthcare planning, made more important given that medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease and constitute a significant proportion of health care expenditure. Pharmacists need to inform policy development that will, in its implementation, offer opportunity to deliver greater rationality, safety, effectiveness and economy to the medicines use process and where patients experience enhanced health outcomes. This is the second of two articles directed to this specific issue focusing on how policy and strategic change can be affected. This is discussed from three overlapping perspectives - from the point of view of skills, that is, the skills or tactics needed to be employed to effect change; secondly, from a structural standpoint in terms of what positional arrangements exist that could be positively exploited; and thirdly, the subject, particularly its relevance to the contemporary situation. These approaches are then exemplified through a worked example on medication safety and its application in practice.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Student > Bachelor 5 19%
Researcher 3 11%
Student > Doctoral Student 2 7%
Student > Ph. D. Student 2 7%
Other 2 7%
Unknown 8 30%
Readers by discipline Count As %
Medicine and Dentistry 5 19%
Pharmacology, Toxicology and Pharmaceutical Science 4 15%
Business, Management and Accounting 2 7%
Nursing and Health Professions 2 7%
Social Sciences 2 7%
Other 3 11%
Unknown 9 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2015.
All research outputs
#13,827,359
of 23,577,761 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#240
of 432 outputs
Outputs of similar age
#179,238
of 360,975 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#7
of 11 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 432 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.